An	O
assay	O
to	O
measure	O
angiogenesis	O
in	O
human	O
fat	B-Tissue
tissue	I-Tissue
.	O

BACKGROUND	O
:	O
Inhibition	O
of	O
angiogenesis	O
reverses	O
rodent	O
obesity	O
.	O

A	O
validated	O
assay	O
in	O
human	O
fat	B-Tissue
tissue	I-Tissue
is	O
needed	O
to	O
study	O
the	O
role	O
of	O
angiogenesis	O
in	O
human	O
obesity	O
.	O

METHODS	O
:	O
Human	O
fat	B-Tissue
tissue	I-Tissue
fragments	I-Tissue
from	O
surgery	O
were	O
placed	O
in	O
96	O
-	O
well	O
plates	O
,	O
embedded	O
in	O
fibrin	O
thrombin	O
clot	B-Organism_substance
and	O
overlaid	O
with	O
cell	B-Cell
culture	O
media	O
containing	O
20	O
%	O
fetal	B-Organism_substance
bovine	I-Organism_substance
serum	I-Organism_substance
.	O

After	O
15	O
days	O
,	O
the	O
clots	B-Organism_substance
were	O
examined	O
by	O
histology	O
and	O
electron	O
microscopy	O
.	O

The	O
effect	O
of	O
taxol	O
,	O
cobalt	O
chloride	O
and	O
a	O
heparin	O
-	O
steroid	O
combination	O
was	O
tested	O
in	O
the	O
fat	B-Tissue
tissue	I-Tissue
assay	O
and	O
compared	O
to	O
the	O
validated	O
human	O
placental	B-Multi-tissue_structure
vein	I-Multi-tissue_structure
angiogenesis	O
model	O
(	O
HPVAM	O
)	O
.	O

RESULTS	O
:	O
Blood	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
initiated	O
growth	O
and	O
elongated	O
from	O
the	O
fat	B-Tissue
tissue	I-Tissue
fragments	I-Tissue
over	O
15	O
days	O
.	O

Presence	O
of	O
blood	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
was	O
confirmed	O
with	O
histology	O
and	O
electron	O
microscopy	O
.	O

Taxol	O
at	O
10	O
(	O
-	O
6	O
)	O
and	O
10	O
(	O
-	O
7	O
)	O
M	O
completely	O
inhibited	O
angiogenesis	O
,	O
while	O
Taxol	O
10	O
(	O
-	O
8	O
)	O
and	O
10	O
(	O
-	O
9	O
)	O
M	O
and	O
the	O
heparin	O
-	O
steroid	O
partially	O
inhibited	O
angiogenesis	O
.	O

The	O
response	O
to	O
taxol	O
and	O
heparin	O
-	O
steroid	O
was	O
similar	O
to	O
that	O
of	O
the	O
HPVAM	O
,	O
a	O
validated	O
angiogenesis	O
assay	O
.	O

Cobalt	O
chloride	O
,	O
a	O
stimulator	O
of	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
stimulated	O
angiogenesis	O
initiation	O
at	O
10	O
(	O
-	O
9	O
)	O
M	O
in	O
fat	B-Tissue
tissue	I-Tissue
and	O
the	O
HPVAM	O
,	O
but	O
at	O
10	O
(	O
-	O
10	O
)	O
M	O
blood	B-Multi-tissue_structure
vessel	I-Multi-tissue_structure
growth	O
was	O
stimulated	O
only	O
in	O
the	O
fat	B-Tissue
assay	O
.	O

CONCLUSION	O
:	O
This	O
angiogenesis	O
assay	O
based	O
on	O
human	O
fat	B-Tissue
tissue	I-Tissue
uses	O
three	O
-	O
dimensionally	O
intact	O
human	O
tissue	B-Tissue
.	O

The	O
vessels	B-Multi-tissue_structure
are	O
derived	O
from	O
quiescient	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
within	O
the	O
fat	B-Tissue
.	O

These	O
properties	O
allow	O
the	O
angiogenic	O
switch	O
to	O
be	O
evaluated	O
in	O
an	O
in	O
vitro	O
setting	O
.	O

The	O
angiogenic	O
response	O
of	O
fat	B-Tissue
tissue	I-Tissue
is	O
not	O
identical	O
to	O
placental	B-Tissue
tissue	I-Tissue
.	O

This	O
assay	O
allows	O
exploration	O
of	O
angiogenesis	O
in	O
fat	B-Tissue
tissue	I-Tissue
.	O

